The Journal of Organic Chemistry
Article
(d, J = 4.5 Hz, C3,5), 22.3 (d, J = 34.5 Hz, C2,6). 31P{1H} NMR (202
MHz, CDCl3): δ 3.2−1.9 (m) ppm. GC−MS (EI, 70 eV) m/z = 192.05
(64), 191.05 (31), 136.05 (18), 125.05 (21), 109.05 (21), 108.05
(100), 107.05 (52), 91.10 (19). Anal. Calcd for C11H16BOP: C, 64.13;
H, 7.83. Found: C, 64.10; H, 7.85.
70.8 Hz, C6). 31P{1H} NMR (202 MHz, CDCl3): δ 16.9 ppm. GC−MS
(EI, 70 eV) m/z = 178.00 (33), 150.00 (19), 132.05 (10), 131.05
(100), 124.00 (24), 103.05 (14). Anal. Calcd for C11H11O2P: C, 64.08;
H, 5.38. Found: C, 64.01; H, 5.24.
1-Phenylphosphin-2-en-4-one 1-Oxide (−)-4a. This compound
was prepared according to the general organocatalytic α-halogenation
procedure from 1a (0.19 g, 1 mmol) to give 0.1 g, (54%) of (−)-4a as
colorless crystals; ([α]2D0 = −152.4 (c 1.1, CHCl3) for ee = 54%); mp =
110.7−113.6 °C; Rf = 0.33 (CHCl3/THF = 10:1). CSP-HPLC
conditions: Chiralcel OD-H, hexane/2-propanol = 90:10, 1 mL/min,
retention time = 27.8 min for the major enantiomer and 32.3 min for
the minor enantiomer. 1H NMR (500 MHz, CDCl3): δ 7.79−7.74 (m,
2H), 7.65−7.60 (m, 1H), 7.58−7.48 (m, 2H), 7.10−7.04 (m, 1H), 6.73
(dd, J = 13.6 and 23.0 Hz, 1H), 3.15 (s, 1H), 2.85−2.73 (m, 1H), 2.62−
2.51 (m, 1H), 2.49−2.40 (m, 1H). 13C{1H} NMR (126 MHz, CDCl3):
δ 196.1 (d, J = 14.5 Hz, C=O), 142.6 (C3), 138.2 (d, J = 83.6 Hz, C2),
132.9 (d, J = 2.7 Hz, Cpara), 130.6 (d, J = 10.9 Hz, Cortho), 129.9 (d, J =
105.4 Hz, Cipso), 129.2 (d, J = 12.7 Hz, Cmeta), 33.8 (d, J = 6.4 Hz, C5),
26.6 (d, J = 70.8 Hz, C6). 31P{1H} NMR (202 MHz, CDCl3): δ 16.9
ppm. GC−MS (EI, 70 eV) m/z = 178.00 (33), 150.00 (19), 132.05
(10), 131.05 (100), 124.00 (24), 103.05 (14). Anal. Calcd for
C11H11O2P: C, 64.08; H, 5.38. Found: C, 64.27; H, 5.43.
1-Phenylphosphin-2-en-4-one 1-Sulfide (rac-4c). This compound
was prepared according to the general one-pot procedure from 1c (0.41
g, 2 mmol) to give 0.19 g, 0.86 mmol, 51% overall yield after two steps,
as colorless crystals; mp = 91.9−92.4 °C; Rf = 0.36 (hexane/THF =
6:1). 1H NMR (500 MHz, CDCl3): δ 7.96−7.89 (m, 2H), 7.66−7.61
(m, 1H), 7.61−7.55 (m, 2H), 7.05−6.95 (m, 1H), 6.63 (dd, J = 12.5
and 34.5 Hz, 1H), 3.30 (tdd, J = 4.6, 12.2 and 16.5 Hz, 1H), 2.95−2.73
(m, 2H), 2.62−2.49 (m, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ
195.6 (d, J = 13.6 Hz, C=O), 139.3 (d, J = 3.6 Hz, C3), 139.2 (d, J = 68.2
Hz, C2), 132.7 (d, J = 3.6 Hz, Cpara), 131.1 (d, J = 11.8 Hz, Cortho), 129.6
(d, J = 85.7 Hz, Cipso), 129.1 (d, J = 11.8 Hz, Cmeta), 34.0 (d, J = 7.3 Hz,
C5), 31.3 (d, J = 55.4 Hz, C6). 31P{1H} NMR (202 MHz, CDCl3): δ
21.3 ppm. GC−MS (EI, 70 eV) m/z = 223.05 (13), 222.05 (100),
190.10 (14), 189.10 (86), 171.10165.05 (10), (12), 143.15 (12),
142.15 (96), 141.15 (18), 140.05 (50), 134.10 (22), 133.10 (50),
131.10 (20), 109.10 (11), 108.10 (28), 107.10 (69), 105.15 (24),
103.10 (18), 91.10 (10), 83.05 (12), 81.05 (11). Anal. Calcd for
C11H11OPS: C, 59.45; H, 4.99. Found: C, 59.39; H, 4.95.
1-Phenylphosphin-2-en-4-one 1-Sulfide (−)-4c. The compound
(−)-4c was prepared according to the general one-pot procedure from
1c (1.1 g, 5 mmol) to give 0.52 g, 2.4 mmol, 48% overall yield after two
steps; colorless oil; ([α]D20 = −86.17 (c 1.5, CHCl3) for ee = 96%); Rf =
0.36 (hexane/THF = 6:1); CSP-HPLC conditions: Chiralcel OJ-H,
hexane/2-propanol = 95:5, 1 mL/min, retention time = 66 min for the
minor enantiomer and 70 min for the major enantiomer. 1H NMR (500
MHz, CDCl3): δ 7.96−7.89 (m, 2H), 7.66−7.61 (m, 1H), 7.61−7.55
(m, 2H), 7.05−6.95 (m, 1H), 6.63 (dd, J = 12.5 and 34.5 Hz, 1H), 3.30
(tdd, J = 4.6, 12.2 and 16.5 Hz, 1H), 2.95−2.73 (m, 2H), 2.62−2.49 (m,
1H). 13C{1H} NMR (126 MHz, CDCl3): δ 195.6 (d, J = 13.6 Hz,
C=O), 139.3 (d, J = 3.6 Hz, C3), 139.2 (d, J = 68.2 Hz, C2), 132.7 (d, J
= 3.6 Hz, Cpara), 131.1 (d, J = 11.8 Hz, Cortho), 129.6 (d, J = 85.7 Hz,
Cipso), 129.1 (d, J = 11.8 Hz, Cmeta), 34.0 (d, J = 7.3 Hz, C5), 31.3 (d, J =
55.4 Hz, C6). 31P{1H} NMR (202 MHz, CDCl3): δ 21.3 ppm. GC−MS
(EI, 70 eV) m/z = 223.05 (13), 222.05 (100), 190.10 (14), 189.10
(86), 171.10165.05 (10), (12), 143.15 (12), 142.15 (96), 141.15 (18),
140.05 (50), 134.10 (22), 133.10 (50), 131.10 (20), 109.10 (11),
108.10 (28), 107.10 (69), 105.15 (24), 103.10 (18), 91.10 (10), 83.05
(12), 81.05 (11). Anal. Calcd for C11H11OPS: C, 59.45; H, 4.99.
Found: C, 59.15; H, 4.78.
1-Phenylphosphin-2,5-dien-4-one 1-Oxide (31a). This compound
was prepared according to the catalytic desymmetrizing dehydrogen-
ation procedure from 1-phenylphosphinan-4-one 1a. 31a: 8 mg, 0.004
mmol, (2%); pale yellow crystals; mp = 131.2−132.6 °C (lit. 130−131
°C);35 Rf = 0.45 (DCM/THF = 6:1); 1H NMR (500 MHz, CDCl3): δ
7.81−7.75 (m, 2H), 7.64 (dd, J = 1.7 and 7.4 Hz, 1H), 7.59−7.54 (m,
2H), 7.16−7.09 (m, 2H), 6.93−6.88 (m, 1H), 6.86−6.81 (m, 1H).
13C{1H} NMR (126 MHz, CDCl3): δ 183.0 (d, J = 25.0 Hz, C=O),
140.4 (d, J = 2.7 Hz, C3,5), 137.8 (d, J = 90.5 Hz, C2,6), 133.2 (d, J =
1-Phenylphosphinan-4-one 1-Sulfide (1c). This compound was
prepared according to the general procedure from 1-phenylphos-
phinan-4-one (1.92 g, 0.01 mol) and elemental sulfur (0.335 g, 0.0105
mol, 1.05 equiv.), in toluene (15 mL). Then, after evaporation of
solvent, the product was recrystallized from Et2O to yield 2.04 g (91%)
of 1c as white crystals; mp = 142.3−145.7 °C (lit. 144−145 °C);34 Rf =
0.26 (hexane/THF = 6:1); 1H NMR (500 MHz, CDCl3): δ 8.00−7.92
(m, 2H), 7.64−7.54 (m, 3H), 3.41−3.26 (m, 2H), 2.82−2.67 (m, 4H),
2.42−2.27 (m, 2H). 13C{1H} NMR (126 MHz, CDCl3): δ 207.0 (d, J =
7.3 Hz, C=O), 132.4 (d, J = 2.7 Hz, Cpara), 130.6 (d, J = 10.9 Hz, Cortho),
130.5 (d, J = 80.2 Hz, Cipso), 129.1 (d, J = 11.8 Hz, Cmeta), 36.8 (d, J =
5.5 Hz, C3,5), 31.2 (d, J = 50.9 Hz, C2,6). 31P{1H} NMR (202 MHz,
CDCl3): δ 32.0 ppm. GC−MS (EI, 70 eV) m/z = 224.05 (100), 225.05
(13), 196.00 (27), 191.10 (24), 168.05 (35), 157.05 (12), 141.05 (13),
140.05 (40), 135.05 (13), 133.05 (17), 125.05 (15), 113.05 (20),
109.10 (18), 108.05 (28), 107.05 (46), 105.10 (45), 91.10 (23), 84.10
(12), 83.10 (41). Anal. Calcd for C11H13OPS: C, 58.91; H, 5.84.
Found: C, 58.86; H, 5.85.
1-Phenyl-4-[(trimethylsilyl)oxy]-1,2,3,6-tetrahydrophosphinine
1-Borane (2b). This compound was prepared according to the general
enantioselective enolization procedure from 1b (21 mg, 0.1 mmol) to
give 5 mg (22%) of 2b as a colorless oil. Due to its very high
susceptibility to hydrolysis under column chromatography conditions,
borane 2b was analyzed and used for oxidation studies only as crude; Rf
= 0.72 (hexane/THF = 8:1); 1H NMR (500 MHz, CDCl3): δ 7.77−
7.72 (m, 2H), 7.55−7.45 (m, 3H), 5.08 (dt, J = 4.4 Hz and 18.6 Hz,
1H), 2.7−2.65 (m, 2H), 2.45−2.35 (m, 1H), 2.20−2.05 (m, 3H), 1.1−
0.4 (bm, 3H), 0.21 (t, J = 3.3 Hz, 9H). 13C{1H} NMR (126 MHz,
CDCl3): δ 151.5 (d, J = 12.7 Hz, C4), 131.3 (d, J = 11.8 Hz, Cmeta),
131.3 (d, J = 6.4 Hz, Cpara), 128.9 (d, J = 10 Hz, Cortho), 128.8 (d, J =
51.8 Hz, Cipso), 99.1 (d, J = 8.2 Hz, C5), 26.0 (d, J = 6.4 Hz, C3), 20.3
(d, J = 34.5 Hz, C6), 19.7 (d, J = 36.4 Hz, C2), 0.3 (C-Si). 31P{1H}
NMR (202 MHz, CDCl3): δ −3.7 ppm. GC−MS (EI, 70 eV) m/z =
265.10 (22), 264.10 (100), 263.10 (45), 249.10 (30), 236.05 (48),
221.05 (11), 190.10 (45), 173.05 (44), 155.10 (35), 141.10 (15),
137.05 (11), 135.10 (17), 133.05 (10), 128.10 (12), 127.05 (75),
121.10 (12), 109.05 (23), 107.05 (17), 91.10 (14), 85.10 (28).
1-Phenyl-4-[(trimethylsilyl)oxy]-1,2,3,6-tetrahydrophosphinine
1-Sulfide (2c). This compound was prepared according to the general
enantioselective enolization procedure from 1c (22 mg, 0.1 mmol) to
give 8 mg (31%) of 2c as a colorless oil. Due to its very high
susceptibility to hydrolysis under column chromatography conditions,
sulfide 2c was analyzed and used for oxidation studies only as crude; Rf
= 0.63 (hexane/THF = 6:1); 1H NMR (500 MHz, CDCl3): δ 7.93−
7.88 (m, 2H), 7.55−7.48 (m, 3 H), 5.01 (dt, J = 4.50 and 26.00 Hz,
1H), 3.11−3.00 (m, 1H), 2.88−2.77 (m, 1H), 2.66−2.53 (m, 1H),
2.47−2.35 (m, 1H), 2.33−2.15 (m, 2H), 0.20 (s, 9H). 13C{1H} NMR
(126 MHz, CDCl3): δ 151.4 (d, J = 15.4 Hz, C4), 132.0 (d, J = 78.1 Hz,
Cipso), 131.7 (d, J = 3.6 Hz, Cpara), 130.4 (d, J = 10.0 Hz, Cortho), 128.8
(d, J = 11.8 Hz, Cmeta), 99.3 (d, J = 8.2 Hz, C5), 29.8 (d, J = 54.5 Hz,
C6), 29.1 (d, J = 51.8 Hz, C2), 27.7 (d, J = 7.3 Hz, C3), 0.3 (C-Si).
31P{1H} NMR (202 MHz, CDCl3): δ 27.2 ppm. GC−MS (EI, 70 eV)
m/z = 296.90 (22), 295.90 (55), 262.90 (16), 156.00 (28), 155.00
(100), 91.00 (13).
1-Phenylphosphin-2-en-4-one 1-Oxide (rac-4a). This compound
was prepared according to the general organocatalytic α-halogenation
procedure from 1a (0.57 g, 3 mmol) to give 0.36 g (64%) of rac-4a as
colorless crystals; mp = 106.7−107.3 °C, Rf = 0.33 (CHCl3/THF =
10:1). 1H NMR (500 MHz, CDCl3): δ 7.79−7.74 (m, 2H), 7.65−7.60
(m, 1H), 7.58−7.48 (m, 2H), 7.10−7.04 (m, 1H), 6.73 (dd, J = 13.6
and 23.0 Hz, 1H), 3.15 (s, 1H), 2.85−2.73 (m, 1H), 2.62−2.51 (m,
1H), 2.49−2.40 (m, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ 196.1
(d, J = 14.5 Hz, C=O), 142.6 (C3), 138.2 (d, J = 83.6 Hz, C2), 132.9 (d,
J = 2.7 Hz, Cpara), 130.6 (d, J = 10.9 Hz, Cortho), 129.9 (d, J = 105.4 Hz,
Cipso), 129.2 (d, J = 12.7 Hz, Cmeta), 33.8 (d, J = 6.4 Hz, C5), 26.5 (d, J =
6203
J. Org. Chem. 2021, 86, 6195−6206